Royalty Pharma
Price & Volume
Stats
See more52W Range | $24.05-$33.69 |
Market Cap | $19.2B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $2.2B |
Revenue Growth (YoY) | -0.4% |
Gross Profit (12 Mos) | $1.5B |
Diluted EPS | $1.91 |
News
See moreYahoo Finance • 10 days ago
Royalty Pharma Announces R&D Funding Collaboration With Biogen
Yahoo Finance • 11 days ago
Royalty Pharma Reports Q4 and Full Year 2024 Results
Yahoo Finance • 25 days ago
Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
Yahoo Finance • 5 months ago
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
About
CEO | Mr. Pablo Gerardo Legorreta |
CFO | Mr. Terrance P. Coyne |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
